Test ID: CMA
Centromere Antibodies, IgG, Serum
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
9278
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Evaluating patients with clinical signs and symptoms compatible with systemic sclerosis including skin involvement, Raynaud’s phenomenon, and arthralgias
As an aid in the diagnosis of calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasis (CREST) syndrome
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Connective Tissue Disease Cascade (CTDC) in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Multiplex Flow Immunoassay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Centromere Ab, IgG, S
Aliases Lists additional common names for a test, as an aid in searching
ACA (Anticentromere Antibodies)
Anti-centromere Antibodies
Anticentromere Antibodies
Centromere Antibodies, IgG
CENTROMERE ANTIBODY
Centromere Autoantibodies
CREST
HEp-2
Scleroderma Antibodies (? FOR SPECIFIC TEST)
Anti-centromere Antibodies
Anticentromere Antibodies
Centromere Antibodies, IgG
CENTROMERE ANTIBODY
Centromere Autoantibodies
CREST
HEp-2
Scleroderma Antibodies (? FOR SPECIFIC TEST)
External
link
PDF
document
Excel
document
Word
document